|  | Below median | Above median |  | ||
---|---|---|---|---|---|---|
 |  | No. of total | No. of events | No. of total | No. of events | HR (95%CI)a |
 | TNM stage |  |  |  |  |  |
Vitamin B2, mg | I-II | 350 | 39 | 466 | 58 | 1.40 (0.85-2.30) |
 | III | 68 | 16 | 96 | 28 | 1.13 (0.52-2.43) |
Vitamin B6, mg | I-II | 362 | 46 | 454 | 51 | 1.02 (0.61-1.73) |
 | III | 74 | 19 | 90 | 25 | 1.05 (0.49-2.27) |
Folate, mg | I-II | 397 | 48 | 419 | 49 | 1.10 (0.69-1.75) |
 | III | 91 | 21 | 73 | 23 | 1.52 (0.77-3.01) |
 | Lymph-node status |  |  |  |  |  |
Vitamin B2, mg | Negative | 242 | 25 | 335 | 35 | 1.28 (0.67-2.42) |
 | Positive | 172 | 29 | 218 | 49 | 1.40 (0.81-2.44) |
Vitamin B6, mg | Negative | 251 | 28 | 326 | 32 | 1.22 (0.63-2.34) |
 | Positive | 181 | 36 | 209 | 42 | 0.88 (0.49-1.56) |
Folate, mg | Negative | 284 | 30 | 293 | 30 | 1.23 (0.68-2.24) |
 | Positive | 199 | 38 | 191 | 40 | 1.12 (0.67-1.87) |
 | Hormone status |  |  |  |  |  |
Vitamin B2, mg | ER + and/or PR+ | 300 | 34 | 398 | 40 | 0.91 (0.52-1.59) |
 | ER–/PR– | 111 | 21 | 153 | 43 | 2.28 (1.20-4.35) |
Vitamin B6, mg | ER + and/or PR+ | 305 | 39 | 393 | 35 | 0.57 (0.32-1.03) |
 | ER–/PR– | 125 | 26 | 139 | 38 | 1.86 (0.97-3.56) |
Folate, mg | ER + and/or PR+ | 333 | 39 | 365 | 35 | 0.82 (0.49-1.40) |
 | ER–/PR– | 148 | 30 | 116 | 34 | 1.84 (1.02-3.32) |
 | Nuclear grade |  |  |  |  |  |
Vitamin B2, mg | I-II | 223 | 23 | 302 | 34 | 1.22 (0.64-2.34) |
 | III | 185 | 32 | 241 | 50 | 1.43 (0.82-2.49) |
Vitamin B6, mg | I-II | 226 | 29 | 299 | 28 | 0.56 (0.28-1.11) |
 | III | 200 | 36 | 226 | 46 | 1.28 (0.73-2.24) |
Folate, mg | I-II | 250 | 31 | 275 | 26 | 0.69 (0.38-1.27) |
 | III | 224 | 38 | 202 | 44 | 1.59 (0.95-2.66) |